Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Terpenoids and Triterpenoid Saponins: Future Treatment for Depression

Author(s): Zaynab Mando, Ragdhaa Hamdan Al Zarzour, Salah Alshehade, Adlin Afzan, Khozirah Shaari, Zurina Hassan, Norlia Mahror and Fauziahanim Zakaria*

Volume 10, Issue 2, 2024

Published on: 23 February, 2023

Article ID: e230223213965 Pages: 18

DOI: 10.2174/2215083809666230223121504

Price: $65

Abstract

Background: Depression is a crippling mental disorder with high prevalence around the world. The available clinical antidepressants have been effective to a certain degree, and different side effects have limited their application. This leads to the necessity of finding new treatments. Herbal plants are a substantial source of new drug leads. Terpenoid compounds are secondary metabolites representing an enormous category of structures found commonly in plants either as aglycones or attached to sugar moieties. These phytochemicals have been extensively studied for their various biological effects, and several have been investigated for potential therapeutic effects in the treatment of depression.

Aim: This review aims to highlight the current knowledge on some terpenoids and triterpenoid saponins as potential antidepressant agents and their mechanisms of action, which may provide a better understanding of the potential antidepressant-like effects of these compounds and lead to the development of auspicious molecules with high efficiency and low side effects for depressive disorders treatment.

Methods: A total of 16 plants containing antidepressant agents are reviewed in this article. 9 terpenoids and 23 triterpenoid saponins compounds have been reported to becommonly found in plant extracts, indicating potential use for depression. To enhance the datum of this review, the mechanism of action for the candidate compounds has been predicted via functional enrichment analysis.

Results: The behavioural and neurochemical effects, as well as the possible mechanisms of action, have been evaluated in rodents by different predictive models of depression, mainly the acute stress models of the forced swimming test (FST) and tail suspension test (TST). The involved mechanisms include enhancing monoamine neurotransmitters, ameliorating brain-derived neurotrophic factor (BDNF), and normalizing the hypothalamus-pituitary-adrenal (HPA) axis. Preclinical studies support the potential antidepressant activities of some terpenoid compounds. Furthermore, the functional enrichment analysis has confirmed the previous pre-clinical findings and predicted further mechanisms of action, including cellular calcium ion homeostasis, cellular response to dopamine, endocrine resistance, and regulating GABAergic, serotonergic, glutamatergic, and dopaminergic synapse, bedsides neurotransmitter reuptake.

Conclusion: Terpenoids and triterpenoid saponins provide a large number of natural compounds. This review sheds light on terpenoids and triterpenoid saponins compounds with antidepressantlike activity and their potential mechanisms of action. However, more evaluations are required to confirm that these compounds are promising for discovering antidepressant drugs.

Graphical Abstract

[1]
World Health Organization Depression. 2017. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
[2]
Hidaka BH. Depression as a disease of modernity: Explanations for increasing prevalence. J Affect Disord 2012; 140(3): 205-14.
[http://dx.doi.org/10.1016/j.jad.2011.12.036] [PMID: 22244375]
[3]
Zhang Y, Long Y, Yu S, et al. Natural volatile oils derived from herbal medicines: A promising therapy way for treating depressive disorder. Pharmacol Res 2021; 164: 105376.
[http://dx.doi.org/10.1016/j.phrs.2020.105376] [PMID: 33316383]
[4]
Kaltenboeck A, Harmer C. The neuroscience of depressive disorders: A brief review of the past and some considerations about the future. Brain Neurosci Adv 2018; 2: 2398212818799269.
[http://dx.doi.org/10.1177/2398212818799269] [PMID: 32166149]
[5]
Kennedy SH. Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues Clin Neurosci 2008; 10(3): 271-7.
[http://dx.doi.org/10.31887/DCNS.2008.10.3/shkennedy] [PMID: 18979940]
[6]
Penn E, Tracy DK. The drugs don’t work? antidepressants and the current and future pharmacological management of depression. Ther Adv Psychopharmacol 2012; 2(5): 179-88.
[http://dx.doi.org/10.1177/2045125312445469] [PMID: 23983973]
[7]
Chand SP, Arif H. Depression. StatPearls-NCBI Bookshelf July 18, 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430847/
[8]
Dome P, Tombor L, Lazary J, Gonda X, Rihmer Z. Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review. Brain Res Bull 2019; 146(7): 51-78.
[http://dx.doi.org/10.1016/j.brainresbull.2018.12.015]
[9]
Li Z, Ruan M, Chen J, Fang Y. Major depressive disorder: Advances in neuroscience research and translational applications. Neurosci Bull 2021; 37(6): 863-80.
[http://dx.doi.org/10.1007/s12264-021-00638-3] [PMID: 33582959]
[10]
Hasler G. Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? World Psychiatry 2010; 9(3): 155-61.
[http://dx.doi.org/10.1002/j.2051-5545.2010.tb00298.x] [PMID: 20975857]
[11]
Jesulola E, Micalos P, Baguley IJ. Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet? Behav Brain Res 2018; 341: 79-90.
[http://dx.doi.org/10.1016/j.bbr.2017.12.025] [PMID: 29284108]
[12]
Chávez-Castillo M, Núñez V, Nava M, et al. Depression as a neuroendocrine disorder: Emerging neuropsychopharmacological approaches beyond monoamines. Adv Pharmacol Sci 2019; 2019: 1-20.
[http://dx.doi.org/10.1155/2019/7943481] [PMID: 30719038]
[13]
Verduijn J, Milaneschi Y, Schoevers RA, van Hemert AM, Beekman ATF, Penninx BWJH. Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression. Transl Psychiatry 2015; 5(9): e649.
[http://dx.doi.org/10.1038/tp.2015.137] [PMID: 26418277]
[14]
de Menezes Galvão AC, Almeida RN, de Sousa GM Jr, et al. Pathophysiology of major depression by clinical stages. Front Psychol 2021; 12(8): 641779.
[http://dx.doi.org/10.3389/fpsyg.2021.641779] [PMID: 34421705]
[15]
Nemeroff CB. The state of our understanding of the pathophysiology and optimal treatment of depression: Glass half full or half empty? Am J Psychiatry 2020; 177(8): 671-85.
[http://dx.doi.org/10.1176/appi.ajp.2020.20060845] [PMID: 32741287]
[16]
Fajemiroye JO, da Silva DM, de Oliveira DR, Costa EA. Treatment of anxiety and depression: Medicinal plants in retrospect. Fundam Clin Pharmacol 2016; 30(3): 198-215.
[http://dx.doi.org/10.1111/fcp.12186] [PMID: 26851117]
[17]
Talha Jawaid RG. A review on herbal plants showing antidepressant activity. Int J Pharm Sci Rev Res 2011; 2(12): 3051-60.
[18]
Bahramsoltani R, Farzaei MH, Farahani MS, Rahimi R. Phytochemical constituents as future antidepressants: a comprehensive review. Rev Neurosci 2015; 26(6): 699-719.
[http://dx.doi.org/10.1515/revneuro-2015-0009] [PMID: 26146123]
[19]
Zhao Z, Wang W, Guo H, Zhou D. Antidepressant-like effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats. Behav Brain Res 2008; 194(1): 108-13.
[http://dx.doi.org/10.1016/j.bbr.2008.06.030] [PMID: 18655806]
[20]
Bhutada P, Mundhada Y, Bansod K, et al. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(6): 955-60.
[http://dx.doi.org/10.1016/j.pnpbp.2010.04.025] [PMID: 20447436]
[21]
Xu Y, Li S, Chen R, et al. Antidepressant-like effect of low molecular proanthocyanidin in mice: Involvement of monoaminergic system. Pharmacol Biochem Behav 2010; 94(3): 447-53.
[http://dx.doi.org/10.1016/j.pbb.2009.10.007] [PMID: 19857512]
[22]
Yao CY, Wang J, Dong D, Qian FG, Xie J, Pan SL. Laetispicine, an amide alkaloid from Piper laetispicum, presents antidepressant and antinociceptive effects in mice. Phytomedicine 2009; 16(9): 823-9.
[http://dx.doi.org/10.1016/j.phymed.2009.02.008] [PMID: 19447013]
[23]
Farah Idayu N, Taufik Hidayat M, Moklas MAM, et al. Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine 2011; 18(5): 402-7.
[http://dx.doi.org/10.1016/j.phymed.2010.08.011] [PMID: 20869223]
[24]
Cícero Bezerra Felipe F, Trajano Sousa Filho J, de Oliveira Souza LE, et al. Piplartine, an amide alkaloid from Piper tuberculatum, presents anxiolytic and antidepressant effects in mice. Phytomedicine 2007; 14(9): 605-12.
[http://dx.doi.org/10.1016/j.phymed.2006.12.015] [PMID: 17399971]
[25]
Dasilva A, Deandrade J, Bevilaqua L, et al. Anxiolytic-, antidepressant- and anticonvulsant-like effects of the alkaloid montanine isolated from Hippeastrum vittatum. Pharmacol Biochem Behav 2006; 85(1): 148-54.
[http://dx.doi.org/10.1016/j.pbb.2006.07.027] [PMID: 16950504]
[26]
Kulkarni SK, Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 2008; 589(1-3): 163-72.
[http://dx.doi.org/10.1016/j.ejphar.2008.05.043] [PMID: 18585703]
[27]
Capra JC, Cunha MP, Machado DG, et al. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: Evidence for the involvement of monoaminergic systems. Eur J Pharmacol 2010; 643(2-3): 232-8.
[http://dx.doi.org/10.1016/j.ejphar.2010.06.043] [PMID: 20599906]
[28]
Xu Q, Pan Y, Yi LT, et al. Antidepressant-like effects of psoralen isolated from the seeds of Psoralea corylifolia in the mouse forced swimming test. Biol Pharm Bull 2008; 31(6): 1109-14.
[http://dx.doi.org/10.1248/bpb.31.1109] [PMID: 18520040]
[29]
Yi LT, Xu Q, Li YC, Yang L, Kong LD. Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(4): 616-24.
[http://dx.doi.org/10.1016/j.pnpbp.2009.03.001] [PMID: 19285110]
[30]
Wurglics M, Schubert-Zsilavecz M. Hypericum perforatum: a ‘modern’ herbal antidepressant: Pharmacokinetics of active ingredients. Clin Pharmacokinet 2006; 45(5): 449-68.
[http://dx.doi.org/10.2165/00003088-200645050-00002] [PMID: 16640452]
[31]
Sanmukhani J, Satodia V, Trivedi J, et al. Efficacy and safety of curcumin in major depressive disorder: A randomized controlled trial. Phytother Res 2014; 28(4): 579-85.
[http://dx.doi.org/10.1002/ptr.5025] [PMID: 23832433]
[32]
Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(2): 439-42.
[http://dx.doi.org/10.1016/j.pnpbp.2006.11.010] [PMID: 17174460]
[33]
Fathinezhad Z, Sewell RDE, Lorigooini Z, Rafieian-Kopaei M. Depression and treatment with effective herbs. Curr Pharm Des 2019; 25(6): 738-45.
[http://dx.doi.org/10.2174/1381612825666190402105803] [PMID: 30947651]
[34]
Wang Z, Zhang R, Yang Q, et al. Recent advances in the biosynthesis of isoprenoids in engineered Saccharomyces cerevisiae Advances in Applied Microbiology. (1st ed.). Elsevier Inc. 2021; p. 114.
[http://dx.doi.org/10.1016/bs.aambs.2020.11.001]
[35]
George KW, Alonso-Gutierrez J, Keasling JD, Lee TS. Isoprenoid drugs, biofuels, and chemicals-artemisinin, farnesene, and beyond. Adv Biochem Eng Biotechnol 2015; 148: 355-89.
[http://dx.doi.org/10.1007/10_2014_288] [PMID: 25577395]
[36]
Ludwiczuk A. Skalicka-Woźniak K, Georgiev MI. Terpenoids.Pharmacognosy. Fundamentals, Applications and Strategy Elsevier 2017; 233-66.
[http://dx.doi.org/10.1016/B978-0-12-802104-0.00011-1]
[37]
Reyes BAS, Dufourt EC, Ross J, Warner MJ, Tanquilut NC, Leung AB. Selected phyto and marine bioactive compounds: Alternatives for the treatment of type 2 diabetes. In: Studies in Natural Products Chemistry. 1st ed Elsevier BV. 2018; 55: pp. 111-43.
[http://dx.doi.org/10.1016/B978-0-444-64068-0.00004-8]
[38]
Moses T, Papadopoulou KK, Osbourn A. Metabolic and functional diversity of saponins, biosynthetic intermediates and semi-synthetic derivatives. Crit Rev Biochem Mol Biol 2014; 49(6): 439-62.
[http://dx.doi.org/10.3109/10409238.2014.953628] [PMID: 25286183]
[39]
Ashour AS, El Aziz MMA, Gomha Melad AS. A review on saponins from medicinal plants: chemistry, isolation, and determination. J Nanomed Res 2019; 7(4): 282-8.
[http://dx.doi.org/10.15406/jnmr.2019.07.00199]
[40]
Biswas T, Dwivedi UN. Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance. Protoplasma 2019; 256(6): 1463-86.
[http://dx.doi.org/10.1007/s00709-019-01411-0] [PMID: 31297656]
[41]
Szakiel A. Pączkowski C, Henry M. Influence of environmental abiotic factors on the content of saponins in plants. Phytochem Rev 2011; 10(4): 471-91.
[http://dx.doi.org/10.1007/s11101-010-9177-x]
[42]
Robinson ESJ. Improving the translational validity of methods used to study depression in animals. Psychopathol Rev 2016; a3(1): 41-63.
[http://dx.doi.org/10.5127/pr.034713]
[43]
Becker M, Pinhasov A, Ornoy A. Animal models of depression: What can they teach us about the human disease? Diagnostics 2021; 11(1): 123.
[http://dx.doi.org/10.3390/diagnostics11010123] [PMID: 33466814]
[44]
Krishnan V, Nestler EJ. Animal models of depression: Molecular perspectives. Curr Top Behav Neurosci 2011; 7(1): 121-47.
[http://dx.doi.org/10.1007/7854_2010_108] [PMID: 21225412]
[45]
Song J, Kim YK. Animal models for the study of depressive disorder. CNS Neurosci Ther 2021; 27(6): 633-42.
[http://dx.doi.org/10.1111/cns.13622] [PMID: 33650178]
[46]
Planchez B, Surget A, Belzung C. Animal models of major depression: Drawbacks and challenges. J Neural Transm 2019; 126(11): 1383-408.
[http://dx.doi.org/10.1007/s00702-019-02084-y] [PMID: 31584111]
[47]
Wang Q, Timberlake MA II, Prall K, Dwivedi Y. The recent progress in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2017; 77: 99-109.
[http://dx.doi.org/10.1016/j.pnpbp.2017.04.008] [PMID: 28396255]
[48]
Abelaira HM, Réus GZ, Quevedo J. Reْus GZ, Quevedo JO. Animal models as tools to study the pathophysiology of depression. Rev Bras Psiquiatr 2013; 35 (Suppl. 2): S112-20.
[http://dx.doi.org/10.1590/1516-4446-2013-1098] [PMID: 24271223]
[49]
Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 2017; 45(D1): D353-61.
[http://dx.doi.org/10.1093/nar/gkw1092] [PMID: 27899662]
[50]
Liu Z, Guo F, Wang Y, et al. BATMAN-TCM: A bioinformatics analysis tool for molecular mechanism of traditional chinese medicine. Sci Rep 2016; 6(1): 21146.
[http://dx.doi.org/10.1038/srep21146] [PMID: 26879404]
[51]
Daina A, Michielin O, Zoete V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 2019; 47(W1): W357-64.
[http://dx.doi.org/10.1093/nar/gkz382] [PMID: 31106366]
[52]
Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015; 43(D1): D447-52.
[http://dx.doi.org/10.1093/nar/gku1003] [PMID: 25352553]
[53]
Melo FHC, Moura BA, de Sousa DP, et al. Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: Involvement of dopaminergic system. Fundam Clin Pharmacol 2011; 25(3): 362-7.
[http://dx.doi.org/10.1111/j.1472-8206.2010.00850.x] [PMID: 20608992]
[54]
Bacanlı M. Limonene and ursolic acid in the treatment of diabetes: Citrus phenolic limonene, triterpenoid ursolic acid, antioxidants and diabetes. In: Diabetes: Oxidative Stress and Dietary AntioxidantsINC 2020.
[http://dx.doi.org/10.1016/B978-0-12-815776-3.00027-9]
[55]
Machado DG, Neis VB, Balen GO, et al. Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice: Evidence for the involvement of the dopaminergic system. Pharmacol Biochem Behav 2012; 103(2): 204-11.
[http://dx.doi.org/10.1016/j.pbb.2012.08.016] [PMID: 22940588]
[56]
Senese NB, Rasenick MM, Traynor JR. The role of G-proteins and G-protein regulating proteins in depressive disorders. Front Pharmacol 2018; 9(11): 1289.
[http://dx.doi.org/10.3389/fphar.2018.01289] [PMID: 30483131]
[57]
Pollier J, Goossens A. Oleanolic acid. Phytochemistry 2012; 77: 10-5.
[http://dx.doi.org/10.1016/j.phytochem.2011.12.022] [PMID: 22377690]
[58]
Fajemiroye JO, Galdino PM, Florentino IF, et al. Plurality of anxiety and depression alteration mechanism by oleanolic acid. J Psychopharmacol 2014; 28(10): 923-34.
[http://dx.doi.org/10.1177/0269881114536789] [PMID: 24920136]
[59]
Nowacki J, Wingenfeld K, Kaczmarczyk M, et al. Steroid hormone secretion after stimulation of mineralocorticoid and NMDA receptors and cardiovascular risk in patients with depression. Transl Psychiatry 2020; 10(1): 109.
[http://dx.doi.org/10.1038/s41398-020-0789-7] [PMID: 32313032]
[60]
Subarnas A, Tadano T, Nakahata N, et al. A possible mechanism of antidepresant activity of beta-amyrin palmitate isolated from lobelia inflata leaves in the forced swimming test. Life Sci 1993; 52(3): 289-96.
[http://dx.doi.org/10.1016/0024-3205(93)90220-W] [PMID: 8423710]
[61]
Zeng Y, Wang J, Huang Q, et al. Cucurbitacin II a: A review of phytochemistry and pharmacology. Phytother Res 2021; 35(8): 4155-70.
[http://dx.doi.org/10.1002/ptr.7077] [PMID: 33724593]
[62]
Zhou SM, Guan SY, Yang L, et al. Cucurbitacin IIa exerts antidepressant-like effects on mice exposed to chronic unpredictable mild stress. Neuroreport 2017; 28(5): 259-67.
[http://dx.doi.org/10.1097/WNR.0000000000000747] [PMID: 28240721]
[63]
Bian X, Zhao Y, Guo X, et al. Chiisanoside, a triterpenoid saponin, exhibits anti-tumor activity by promoting apoptosis and inhibiting angiogenesis. RSC Adv 2017; 7(66): 41640-50.
[http://dx.doi.org/10.1039/C7RA08041G]
[64]
Bian X, Liu X, Liu J, et al. Study on antidepressant activity of chiisanoside in mice. Inter Immunopharmac 2018; 57(12): 33-42.
[http://dx.doi.org/10.1016/j.intimp.2018.02.007]
[65]
Zhu L, Chi T, Zhao X, et al. Xanthoceraside modulates neurogenesis to ameliorate cognitive impairment in APP/PS1 transgenic mice. J Physiol Sci 2018; 68(5): 555-65.
[http://dx.doi.org/10.1007/s12576-017-0561-9] [PMID: 28744803]
[66]
Guan W, Gu JH, Ji CH, et al. Xanthoceraside administration produces significant antidepressant effects in mice through activation of the hippocampal BDNF signaling pathway. Neurosci Lett 2021; 757(5): 135994.
[http://dx.doi.org/10.1016/j.neulet.2021.135994] [PMID: 34058291]
[67]
Haghighatdoost F, Feizi A, Esmaillzadeh A, et al. Drinking plain water is associated with decreased risk of depression and anxiety in adults: Results from a large cross-sectional study. World J Psychiatry 2018; 8(3): 88-96.
[http://dx.doi.org/10.5498/wjp.v8.i3.88] [PMID: 30254979]
[68]
Graziani V, Scognamiglio M, Esposito A, Fiorentino A, D’Abrosca B. Chemical diversity and biological activities of the saponins isolated from Astragalus genus: focus on Astragaloside IV.IV In: Phytochemistry Reviews (Vol 18, Issue 4) Netherlands:Springer . 2019.
[http://dx.doi.org/10.1007/s11101-019-09626-y]
[69]
Zhang J, Wu C, Gao L, Du G, Qin X. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects Advances in Pharmacology. (1st ed.). Elsevier Inc. 2020; p. 87.
[http://dx.doi.org/10.1016/bs.apha.2019.08.002]
[70]
Abd Elkader HTAE, Abdou HM, Khamiss OA, Essawy AE. Anti-anxiety and antidepressant-like effects of astragaloside IV and saponins extracted from Astragalus spinosus against the bisphenol A-induced motor and cognitive impairments in a postnatal rat model of schizophrenia. Environ Sci Pollut Res Int 2021; 28(26): 35171-87.
[http://dx.doi.org/10.1007/s11356-021-12927-5] [PMID: 33666843]
[71]
He JG, Zhou HY, Wang F, Chen JG. Dysfunction of glutamatergic synaptic transmission in depression: Focus on AMPA receptor trafficking. Biol Psychiatry Glob Open Sci 2022. In Press
[http://dx.doi.org/10.1016/j.bpsgos.2022.02.007]
[72]
Xu P, Yu B. Chemical synthesis of saponins: An updateAdvances in Carbohydrate Chemistry and Biochemistry. Academic Press 2021; Vol. 79: pp. 1-62.
[http://dx.doi.org/10.1016/bs.accb.2021.11.001]
[73]
Yang Y, Laval S, Yu B. Chemical Synthesis of SaponinsAdvances in Carbohydrate Chemistry and Biochemistry. Academic Press 2014; Vol. 71: pp. 137-226.
[http://dx.doi.org/10.1016/B978-0-12-800128-8.00002-9]
[74]
Jiang N, Lv J, Wang H, et al. Antidepressant‐like effects of 20(S)‐protopanaxadiol in a mouse model of chronic social defeat stress and the related mechanisms. Phytother Res 2019; 33(10): 2726-36.
[http://dx.doi.org/10.1002/ptr.6446] [PMID: 31353678]
[75]
Xu C, Teng J, Chen W, et al. 20(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(8): 1402-11.
[http://dx.doi.org/10.1016/j.pnpbp.2010.07.010] [PMID: 20647027]
[76]
Dhingra D, Sharma A. Evaluation of antidepressant-like activity of glycyrrhizin in mice. Indian J Pharmacol 2005; 37(6): 390-4.
[http://dx.doi.org/10.4103/0253-7613.19077]
[77]
Dang H, Chen Y, Liu X, et al. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(8): 1417-24.
[http://dx.doi.org/10.1016/j.pnpbp.2009.07.020] [PMID: 19632285]
[78]
Xiang H, Liu Y, Zhang B, et al. The antidepressant effects and mechanism of action of total saponins from the caudexes and leaves of Panax notoginseng in animal models of depression. Phytomedicine 2011; 18(8-9): 731-8.
[http://dx.doi.org/10.1016/j.phymed.2010.11.014] [PMID: 21273053]
[79]
Wan J, Zhang Q, Ye W, Wang Y. Quantification and separation of protopanaxatriol and protopanaxadiol type saponins from Panax notoginseng with macroporous resins. Separ Purif Tech 2008; 60(2): 198-205.
[http://dx.doi.org/10.1016/j.seppur.2007.08.007]
[80]
Gray NE, Alcazar Magana A, Lak P, et al. Centella asiatica – Phytochemistry and mechanisms of neuroprotection and cognitiveenhancement. Phytochemistry Reviews Proceedings of the Phytochemical Society of Europe. Phytochem Rev 2018; 17(1): 161-94.
[http://dx.doi.org/10.1007/s11101-017-9528-y] [PMID: 31736679]
[81]
Chen Y, Han T, Qin L, Rui Y, Zheng H. Effect of total triterpenes from Centella asiatica on the depression behavior and concentration of amino acid in forced swimming mice. Zhong Yao Cai 2003; 26(12): 870-3.
[82]
Chen Y, Han T, Rui Y, Yin M, Qin L, Zheng H. Effects of total triterpenes of Centella asiatica on the corticosterone levels in serum and contents of monoamine in depression rat brain. Zhong Yao Cai 2005; 28(6): 492-6.
[83]
Kalshetty P, Aswar U, Bodhankar S, Sinnathambi A, Mohan V, Thakurdesai P. Antidepressant effects of standardized extract of Centella asiatica L. in olfactory bulbectomy model. Biomed Aging Pathol 2012; 2(2): 48-53.
[http://dx.doi.org/10.1016/j.biomag.2012.03.005]
[84]
Liang X, Xu N, Cui S, et al. Antidepressant-like effect of asiaticoside in mice. Pharmacol Biochem Behav 2008; 89(3): 444-9.
[http://dx.doi.org/10.1016/j.pbb.2008.01.020] [PMID: 18325568]
[85]
Luo L, Liu XL, Mu RH, et al. Hippocampal BDNF signaling restored with chronic asiaticoside treatment in depression-like mice. Brain Res Bull 2015; 114: 62-9.
[http://dx.doi.org/10.1016/j.brainresbull.2015.03.006] [PMID: 25857945]
[86]
Girish C, Sanjay S. The antidepressant-like activity of asiatic acid in albino mice involves the monoaminergic system. Indian J Physiol Pharmacol 2020; 64(1): 59-68.
[87]
Li TZ, Zhang WD, Yang GJ, Liu WY, Chen HS, Shen YH. Saponins from Polygala japonica and their effects on a forced swimming test in mice. J Nat Prod 2006; 69(4): 591-4.
[http://dx.doi.org/10.1021/np050439a] [PMID: 16643032]
[88]
He X, Luan F, Yang Y, et al. Passiflora edulis: An insight into current researches on phytochemistry and pharmacology. Front Pharmacol 2020; 11: 617.
[http://dx.doi.org/10.3389/fphar.2020.00617] [PMID: 32508631]
[89]
Wang C, Xu FQ, Shang JH, et al. Cycloartane triterpenoid saponins from water soluble of Passiflora edulis Sims and their antidepressant-like effects. J Ethnopharmacol 2013; 148(3): 812-7.
[http://dx.doi.org/10.1016/j.jep.2013.05.010] [PMID: 23702036]
[90]
Sairam K, Dorababu M, Goel RK, Bhattacharya SK. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine 2002; 9(3): 207-11.
[http://dx.doi.org/10.1078/0944-7113-00116] [PMID: 12046860]
[91]
Zhou Y, Shen YH, Zhang C, Su J, Liu RH, Zhang WD. Triterpene saponins from Bacopa monnieri and their antidepressant effects in two mice models. J Nat Prod 2007; 70(4): 652-5.
[http://dx.doi.org/10.1021/np060470s] [PMID: 17343408]
[92]
Yadav A. A new triterpenoid saponin from tubers of Gloriosa superba Linn. Chem Sci Rev Lett 2014; 3(11): 698-704.
[93]
Jiang D, Gao QP, Shi SP, Tu PF. Triterpenoid saponins from the fruits of Akebiae quinata. Chem Pharm Bull 2006; 54(5): 595-7.
[http://dx.doi.org/10.1248/cpb.54.595] [PMID: 16651751]
[94]
Zhou D, Jin H, Lin HB, et al. Antidepressant effect of the extracts from Fructus akebiae. Pharmacol Biochem Behav 2010; 94(3): 488-95.
[http://dx.doi.org/10.1016/j.pbb.2009.11.003] [PMID: 19931301]
[95]
Wankhede SS, Gambhire M, Juvekar A. Couroupita guianensis Aubl: Evaluation of its antidepressant activity in mice. Pharmacologyonline 2009; 2: 999-1013.
[96]
Zhu W, Ma S, Qu R, Kang D. Antidepressant-like effect of saponins extracted from Chaihu-jia-longgu-muli-tang and its possible mechanism. Life Sci 2006; 79(8): 749-56.
[http://dx.doi.org/10.1016/j.lfs.2006.02.015] [PMID: 16546221]
[97]
Machado CS, Mokochinski JB, Onofre De Lira T, et al. Comparative study of chemical composition and biological activity of yellow, green, brown, and red Brazilian propolis. Medical benefits of honeybee products. J Evid Based Complementary Altern Med 2016. Article ID 6057650
[http://dx.doi.org/10.1155/2016/6057650]
[98]
Ghani U. Terpenoids and steroids. n: Alpha-glucosidase inhibitors clinically promising candidates for anti-diabetic drug discovery. 2020; pp. 101-7.
[http://dx.doi.org/10.1016/B978-0-08-102779-0.00004-6]
[99]
Yu K, Chen F, Li C. Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more? Curr Drug Metab 2012; 13(5): 577-98.
[http://dx.doi.org/10.2174/1389200211209050577] [PMID: 22292787]
[100]
Li SX, Mu Y, Zheng FY. Influence of gastrointestinal digestion and edible plant combination on oral bioavailability of triterpene saponins, using a biomimetic digestion and absorption system and determination by HPLC. J Agric Food Chem 2013; 61(44): 10599-603.
[http://dx.doi.org/10.1021/jf402993a] [PMID: 24099303]
[101]
Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003; 31(8): 1065-71.
[http://dx.doi.org/10.1124/dmd.31.8.1065] [PMID: 12867496]
[102]
Abbas G, Rauf K, Mahmood W. Saponins: the phytochemical with an emerging potential for curing clinical depression. Nat Prod Res 2015; 29(4): 302-7.
[http://dx.doi.org/10.1080/14786419.2014.942661] [PMID: 25075957]
[103]
da Silveira CCSM, Fernandes LMP, Silva ML, et al. Neurobehavioral and antioxidant effects of ethanolic extract of yellow propolis. Oxid Med Cell Longev 2016; 2016: 1-14.
[http://dx.doi.org/10.1155/2016/2906953] [PMID: 27822336]
[104]
Zhang LL, Xu W, Xu YL, Chen X, Huang M, Lu JJ. Therapeutic potential of Rhizoma alismatis: A review on ethnomedicinal application, phytochemistry, pharmacology, and toxicology. Ann N Y Acad Sci 2017; 1401(1): 90-101.
[http://dx.doi.org/10.1111/nyas.13381] [PMID: 28662316]
[105]
Kharkwal H. Foaming glycosides: A review. IOSR J Pharm 2012; 2(5): 23-8.
[http://dx.doi.org/10.9790/3013-25202328]
[106]
Zhang LL, Huang MY, Yang Y, et al. Bioactive platycodins from Platycodonis Radix: Phytochemistry, pharmacological activities, toxicology and pharmacokinetics. Food Chem 2020; 327: 127029.
[http://dx.doi.org/10.1016/j.foodchem.2020.127029] [PMID: 32450486]
[107]
Mancuso C, Santangelo R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem Toxicol 2017; 107((Pt A)): 362-72.
[http://dx.doi.org/10.1016/j.fct.2017.07.019] [PMID: 28698154]
[108]
Montesano D, Rocchetti G, Putnik P, Lucini L. Bioactive profile of pumpkin: An overview on terpenoids and their health-promoting properties. Curr Opin Food Sci 2018; 22: 81-7.
[http://dx.doi.org/10.1016/j.cofs.2018.02.003]
[109]
Li L, Hou X, Xu R, Liu C, Tu M. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol 2017; 31(1): 17-36.
[http://dx.doi.org/10.1111/fcp.12232] [PMID: 27567103]
[110]
Liu J, Lu YF, Wu Q, Xu SF, Shi FG, Klaassen CD. Oleanolic acid reprograms the liver to protect against hepatotoxicants, but is hepatotoxic at high doses. Liver Int 2019; 39(3): 427-39.
[http://dx.doi.org/10.1111/liv.13940] [PMID: 30079536]
[111]
Prasesti GK, Kurniati NF. Toxicity studies of Centella asiatica for drug development: Mini review. Biointerface Res Appl Chem 2021; 12(6): 8081-93.
[http://dx.doi.org/10.33263/BRIAC126.80818093]
[112]
Ruiz-Rodrيguez MA Vedani A, Flores-Mireles AL, Chلirez-Ramيrez MH, Gallegos-Infante JA, Gonzلlez-Laredo RF. In silico prediction of the toxic potential of lupeol. Chem Res Toxicol 2017; 30(8): 1562-71.
[http://dx.doi.org/10.1021/acs.chemrestox.7b00070] [PMID: 28654752]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy